Comparative Efficacy of Omega-3 Fatty Acid with Other Interventions for Depression in Children and Adolescents: A Systematic Review and Network Meta-Analysis
Vergleichende Wirksamkeit von Omega-3-Fettsäuren mit anderen Interventionen bei Depressionen bei Kindern und Jugendlichen: systematische Übersicht und Netzwerk-Metaanalyse
Journal of Child and Adolescent Psychopharmacology · 2024-09 · 34 (7) · 282-291
DOI: 10.1089/cap.2024.0017 ↗Auf einen Blick
Neun Studien mit 561 Teilnehmenden untersuchten Omega-3 und Kombinationstherapien bei Depressionen im Kindes- und Jugendalter. Gegenüber Placebo zeigte keine Intervention eine signifikante Besserung der Depressionssymptome.
Fragestellung
Wie wirksam sind Omega-3 und Kombinationstherapien bei Depressionen bei Kindern und Jugendlichen, auch im Hinblick auf Remission?
Methode
Systematische Übersicht und Netzwerk-Metaanalyse; Suche in PubMed/EMBASE von Beginn an bis Oktober 2023; Analyse mit Stata 17.0.
Ergebnisse
9 Studien mit 561 Teilnehmenden. Kein signifikanter Vorteil gegenüber Placebo für Depressionssymptome. Omega-3 plus Psychoedukationspsychotherapie senkte die Remissionsrate vs. Placebo (standardized mean difference 0,44; 95 %-KI 0,00–0,87; p = 0,048); Remissionsrate 91,5 %.
Schlussfolgerung der Autor:innen
Die Netzwerk-Metaanalyse liefert nach Angaben der Autor:innen überzeugende Evidenz für antidepressiv wirksame Effekte von Omega-3 bei Kindern und Jugendlichen mit Depression.
Kernaussagen
- Keine signifikante Symptomverbesserung gegenüber Placebo
- Omega-3 plus Psychoedukationspsychotherapie mit geringerer Remissionsrate vs. Placebo
- Omega-3 plus Inositol laut Ranking am wirksamsten
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, online erschienen am 16.09.2024. Verfasst von Chifong Lam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing, P. R. China. Hauptthemen laut MEDLINE: Major Depressive Disorder, Dietary Supplements, Fatty Acids, Omega-3. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Themen: Depression, Kinderkrankenpflege
Abstract (Originalsprache)
Background
The administration of omega-3 polyunsaturated fatty acid supplements is recommended as an adjuvant therapy for adults diagnosed with major depressive disorder. The evaluation of replicated data in combination treatment with omega-3 has been extensively conducted in adults over the past decade. However, the generalizability of these findings to pediatric groups is still uncertain. The objectives of this evaluation were twofold: (1) to evaluate the effectiveness of omega-3 and associated combination therapies in reducing the severity of depressive symptoms, and (2) to include remission rates (i.e., reduction of more than 50% in depression symptoms) as a measure of therapeutic efficacy.
Methods
We conducted a literature search on PubMed/EMBASE from inception to October 2023. Data analyses were conducted using Stata (version 17.0).
Results
We identified a total of 3168 articles. After eligibility screening of identified studies, nine studies (n = 561 participants) were included in our analysis herein. Pairwise comparisons revealed no significant improvement in depression symptoms for any intervention versus placebo. However, a clustered ranking plot identified omega-3 plus inositol as the most effective treatment for pediatric depression (77.3% efficacy). Omega-3 paired with psychoeducational psychotherapy significantly lowered the remission rate compared to placebo (standardized mean difference = 0.44, 95% confidence interval: 0.00–0.87, p = 0.048), resulting in a 91.5% remission rate, making it the most effective treatment in the study.
Conclusions
Taken together, this network meta-analysis presents compelling evidence supporting the antidepressant effects of omega-3 in pediatric groups with depression. Future research should aim to investigate omega-3 as monotherapy for young individuals with depression, as well as investigate the efficacy of omega-3 in comparison to psychosocial interventions for affected individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing, P. R. China.
- The First Affiliated Hospital of Xi'an Medical University, Xi An, China.
- Brain and Cognition Discovery Foundation, Toronto, Canada.
- Department of Psychiatry, University of Toronto, Toronto, Canada.
- Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
- National Demonstration Center for Experimental Psychology Education, Southwest University, Chongqing, P. R. China.
ORCID-Profile: Bing Cao
Zitieren
APA
Lam, C., Han, L., McIntyre, R. S., Teopiz, K. M., & Cao, B. (2024). Comparative Efficacy of Omega-3 Fatty Acid with Other Interventions for Depression in Children and Adolescents: A Systematic Review and Network Meta-Analysis. Journal of Child and Adolescent Psychopharmacology, 34(7), 282-291. https://doi.org/10.1089/cap.2024.0017
Vancouver
Lam C, Han L, McIntyre RS, Teopiz KM, Cao B. Comparative Efficacy of Omega-3 Fatty Acid with Other Interventions for Depression in Children and Adolescents: A Systematic Review and Network Meta-Analysis. Journal of Child and Adolescent Psychopharmacology. 2024;34(7):282-291. doi:10.1089/cap.2024.0017
BibTeX
@article{Lam2024,
author = {Lam, Chifong and Han, Lin and McIntyre, Roger S and Teopiz, Kayla M and Cao, Bing},
title = {Comparative Efficacy of Omega-3 Fatty Acid with Other Interventions for Depression in Children and Adolescents: A Systematic Review and Network Meta-Analysis},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2024},
volume = {34},
number = {7},
pages = {282--291},
doi = {10.1089/cap.2024.0017}
}
EUVIMED